Before they infect red blood cells and cause malaria, Plasmodium parasites undergo an obligate and clinically silent expansion phase in the liver that is supposedly undetected by the host. Here, we demonstrate the engagement of a type I interferon (IFN) response during Plasmodium replication in the liver. We identified Plasmodium RNA as a previously unrecognized pathogenassociated molecular pattern (PAMP) capable of activating a type I IFN response via the cytosolic pattern recognition receptor Mda5. This response, initiated by liver-resident cells through the adaptor molecule for cytosolic RNA sensors, Mavs, and the transcription factors Irf3 and Irf7, is propagated by hepatocytes in an interferon-a/b receptor-dependent manner. This signaling pathway is critical for immune cell-mediated host resistance to liver-stage Plasmodium infection, which we find can be primed with other PAMPs, including hepatitis C virus RNA. Together, our results show that the liver has sensor mechanisms for Plasmodium that mediate a functional antiparasite response driven by type I IFN. (Ifnar1 −/− mice), using our previously published wild-type data 10 as a control. None of the genes differentially expressed in C57BL/6 wild-type (WT) mice in response to P. berghei infection were upregulated in the Ifnar1 −/− mice (Fig. 1a,b and Supplementary Table 1) . We validated these differences by measuring the expression of several ISGs at the transcript (Ifit1, Ifi44, Usp18, Ifit3 and Irf7; used throughout as a readout for type I IFN pathway activation) and protein (Ifit1 and Dai) levels by quantitative RT-PCR (qRT-PCR) and western blot analysis, respectively ( Fig. 1c and Supplementary  Fig. 1 ). Induction of the type I IFN response was further visualized in liver slices of infected mice expressing lacZ under the control of the promoter of Ifit1 (which encodes interferon-induced protein with tetratricopeptide repeats 1) 13 (Supplementary Fig. 1 ). The magnitude of the response upon infection was dose dependent (Fig. 1d ) and detectable after initiation of infection by mosquito bite ( Fig. 1e and Supplementary Fig. 1 ). Time-course analysis first indicated significant ISG induction 36 h after infection, during the parasite replication phase. ISG induction peaked at 42 h, still before the release of hepatic merozoites into the blood ( Fig. 1f and Supplementary Fig. 1 ). Notably, we have shown that the IFN response is undetectable or impaired in mice infected with parasites that arrest before extensive replication [14] [15] [16] , with degree of response correlating with stage of parasite arrest; heat-inactivated sporozoites, which cannot invade hepatocytes, are completely unable to evoke a response ( Fig. 1d and Supplementary Fig. 1 ). Another Plasmodium species able to infect rodents (Plasmodium yoelii) was also able to induce a type I IFN response in WT mice but not in Ifnar1 −/− mice (Fig. 1g) . Furthermore, P. berghei induced a similar response in WT BALB/c mice, as well ( Fig. 1h) , which indicates that induction of a type I IFN response is restricted to neither Plasmodium species nor mouse host strain. The fact that the P. berghei-induced type I IFN response is detectable in whole-liver extracts even after physiological mosquito bite infection with few sporozoites (leading to a small ratio of infected over uninfected hepatocytes) strongly suggests a mechanism of amplification of the signaling, as usually described for the type I IFN response. Thus, we next investigated which cell types in the liver are required for the propagation of the type I IFN response. P. berghei-infected mice lacking Ifnar1 specifically on myeloid cells including macrophages and neutrophils (LysM-Cre-Ifnar1 flox/flox mice) showed no reduction in the induction of ISGs compared to the WT mice, whereas the response was completely impaired in mutant mice lacking Ifnar1 specifically on hepatocytes (Alb-Cre-Ifnar1 flox/flox mice) (Fig. 1i) . Altogether, to our knowledge, our data reveal for the first time that Plasmodium liver-stage infection induces a typical type I IFN signature in the liver of infected mice, with hepatocytes being the primary source of the ISG expression.
Despite renewed eradication efforts by the international community, malaria still exerts an enormous disease burden, with nearly half the planet's population at risk for infection. There is a general consensus that the development of new intervention strategies is hampered by the current limited understanding of the biology of Plasmodium species and of the complex relationships that the parasite maintains with its hosts 1 . Malaria infection is initiated when sporozoites, injected by a female Anopheles mosquito, travel to the liver and infect hepatocytes, ultimately producing thousands of merozoites that will subsequently infect erythrocytes 2 . Whereas the liver stage of infection is clinically silent, erythrocyte infection leads to malaria and all its complications 2, 3 . This symptomatically silent feature of Plasmodium liver-stage infection, in such an immunoprivileged organ as the liver 4 , led to the widespread assumption that Plasmodium can infect and replicate inside hepatocytes undetected 2, 5 . Nonetheless, we and others have reported the presence of inflammatory cells in the livers of infected mice [6] [7] [8] [9] . Moreover, we have shown that in the absence of the host anti-inflammatory molecule heme oxygenase-1, liver-stage infection is impaired owing to a strong inflammatory response 6 . These findings suggest that the host senses Plasmodium hepatocyte infection and responds to it. However, the mechanisms used by the host to detect Plasmodium and mount an inflammatory response remain completely unknown 5 .
RESULTS

Plasmodium liver-stage infection induces a type I IFN response
A comparison of a recently generated liver transcriptome 10 between Plasmodium berghei sporozoite-infected mice and mock-infected mice (mice injected with an equivalent amount of noninfected salivary gland extract) revealed a statistically significant difference in the expression of 1,088 transcripts (P < 0.05, Fig. 1a and Supplementary Table 1 ). Of those, 89 transcripts were at least twofold induced (P < 0.002, Fig. 1b and Supplementary Table 1 ). Remarkably, all 89 genes were interferon-stimulated genes (ISGs) linked to the type I IFN signaling pathway 11 (Supplementary Table 1 ). One main feature of the type I IFN response is the production and secretion of IFN-α and IFN-β, which signal in an autocrine or paracrine manner via the single interferon α receptor (IFNAR) composed of IFNAR1 and IFNAR2, ultimately inducing the expression of ISGs, known to mediate functional antiviral responses 12 . To confirm the activation of a host type I IFN response during Plasmodium liver infection, we analyzed by microarrays the expression of ISGs in mice lacking Ifnar1 (Ifnar1 −/− mice), using our previously published wild-type data 10 as a control. None of the genes differentially expressed in C57BL/6 wild-type (WT) mice in response to P. berghei infection were upregulated in the Ifnar1 −/− mice (Fig. 1a,b and Supplementary Table 1) . We validated these differences by measuring the expression of several ISGs at the transcript (Ifit1, Ifi44, Usp18, Ifit3 and Irf7; used throughout as a readout for type I IFN pathway activation) and protein (Ifit1 and Dai) levels by quantitative RT-PCR (qRT-PCR) and western blot analysis, respectively ( Fig. 1c and Supplementary  Fig. 1) . Induction of the type I IFN response was further visualized in liver slices of infected mice expressing lacZ under the control of the promoter of Ifit1 (which encodes interferon-induced protein with tetratricopeptide repeats 1) 13 (Supplementary Fig. 1 ). The magnitude of the response upon infection was dose dependent (Fig. 1d) and detectable after initiation of infection by mosquito bite ( Fig. 1e and Supplementary Fig. 1 ). Time-course analysis first indicated significant ISG induction 36 h after infection, during the parasite replication phase. ISG induction peaked at 42 h, still before the release of hepatic merozoites into the blood ( Fig. 1f and Supplementary Fig. 1 ). Notably, we have shown that the IFN response is undetectable or impaired in mice infected with parasites that arrest before extensive replication [14] [15] [16] , with degree of response correlating with stage of parasite arrest; heat-inactivated sporozoites, which cannot invade hepatocytes, are completely unable to evoke a response ( Fig. 1d and Supplementary Fig. 1 ). Another Plasmodium species able to infect rodents (Plasmodium yoelii) was also able to induce a type I IFN response in WT mice but not in Ifnar1 −/− mice (Fig. 1g) npg response in WT BALB/c mice, as well ( Fig. 1h) , which indicates that induction of a type I IFN response is restricted to neither Plasmodium species nor mouse host strain. The fact that the P. berghei-induced type I IFN response is detectable in whole-liver extracts even after physiological mosquito bite infection with few sporozoites (leading to a small ratio of infected over uninfected hepatocytes) strongly suggests a mechanism of amplification of the signaling, as usually described for the type I IFN response. Thus, we next investigated which cell types in the liver are required for the propagation of the type I IFN response. P. berghei-infected mice lacking Ifnar1 specifically on myeloid cells including macrophages and neutrophils (LysM-Cre-Ifnar1 flox/flox mice) showed no reduction in the induction of ISGs compared to the WT mice, whereas the response was completely impaired in mutant mice lacking Ifnar1 specifically on hepatocytes (Alb-Cre-Ifnar1 flox/flox mice) (Fig. 1i) . Altogether, to our knowledge, our data reveal for the first time that Plasmodium liver-stage infection induces a typical type I IFN signature in the liver of infected mice, with hepatocytes being the primary source of the ISG expression.
Plasmodium RNA induces type I IFN through Mda5 and Mavs
Having demonstrated that Plasmodium liver-stage infection specifically induces a typical type I IFN signature in the livers of infected mice, we next sought to identify the molecules involved in this induction.
Regardless of which pattern recognition receptor (PRR) initiates the type I IFN response, all the signaling pathways described so far converge upon two downstream transcription factors, interferon regulatory factor (IRF3) and IRF7, which regulate the transcription of type I IFNs 17 (Fig. 2a) . As expected, the type I IFN response was significantly impaired in Irf3 −/− and Irf7 −/− mice, as well as in Irf3 −/− ; Irf7 −/− mice, demonstrating that both Irf3 and Irf7 are critical mediators of the host type I IFN response to P. berghei liver-stage infection (Fig. 2b) . We then established Irf3 −/− bone marrow-chimeric mice to address the respective roles of liver-resident cells (such as hepatocytes) and circulating immune cells (such as neutrophils) in initiating the P. berghei -induced type I IFN response. Whereas Irf3 expression was dispensable in circulating immune cells, it was required in liverresident cells to induce the type I IFN response during P. berghei liver-stage infection (Fig. 2b) , demonstrating that recognition of a PAMP from P. berghei occurs in a liver-resident cell.
We next sought to identify the PRR pathway responsible for the sensing event initiating the type I IFN response. Type I IFN production can be triggered by various PRRs, such as transmembrane Toll-like receptors (including TLR2, TLR3, TLR4, TLR5, TLR7 and TLR9) 18, 19 and cytosolic RNA and DNA sensors. As all TLRs signal through at least one of two possible adaptors, myeloid differentiation factor 88 (MyD88) and TIR-domain-containing adapter-inducing interferon-β (TRIF), we next tested their function in the Plasmodium-induced (Fig. 2c,d ), which suggests that TLRs are not the sensors responsible for driving the type I IFN response during liver-stage infection. An alternative pathway of type I IFN induction proceeds through the mitochondrial antiviral signaling protein (MAVS; also known as CARDIF, VISA and IPS1) [20] [21] [22] [23] . Mavs −/− mice were not able to induce the expression of ISGs after P. berghei liver-stage infection (Fig. 2e) , showing that Mavs is a key molecule in the induction of the type I IFN response during P. berghei infection. Collectively, these data show that the Plasmodiummediated induction of the type I IFN response requires signaling through Mavs and is independent of TLR signaling. Two known cytoplasmic PRRs of the family of retinoic acidinducible gene-I (RIG-I)-like receptors (RLRs), RIG-I and melanoma differentiation-associated gene 5 (MDA5), are known to trigger a MAVS-dependent type I IFN response. Although both RIG-I and MDA5 have been shown to sense viral RNA [24] [25] [26] , it is not known whether either is able to sense RNA from protozoan parasites. Thus, we assessed whether Plasmodium RNA could be a PAMP capable of eliciting a type I IFN response through either RIG-I or MDA5. Transfection of RNA from various Plasmodium species (P. berghei, P. yoelii and P. falciparum) into bone marrow-derived dendritic cells or mouse WT, Mda5 −/− and Ddx58 −/− (here called Rig-I −/− ) primary hepatocytes led to the production of type I IFNs in a Rig-I-independent but Mda5-dependent manner (Supplementary Fig. 2) . Still, we examined the ability of both Rig-I −/− and Mda5 −/− mice to mount a type I IFN response after Plasmodium infection. Consistent with our results from Plasmodium RNA transfection experiments, the type I IFN response was significantly impaired in infected Mda5 −/− but not Rig-I −/− mice compared to WT controls (Fig. 2f,g ). Hydrodynamic tail vein injection of purified P. berghei RNA in vivo also induced a partial Mda5-dependent type I IFN response (Fig. 2h) . Overall, our data show that Plasmodium RNA is a PAMP recognized by Mda5 but not Rig-I and that during infection, liver-resident cells sense Plasmodium parasites via Mda5 and yet unknown other receptors.
The type I IFN response is required for in vivo host defense Type I IFN responses are known to be critical for host defense against viral infections, but their efficacy against bacterial and parasitic infections is still poorly defined 27, 28 . In our model, Ifnar1 −/− and Irf3 −/− mice exhibited a significant increase in parasite liver load at 48 h after P. berghei sporozoite injection, or after mosquito bite infection with P. berghei-infected mosquitoes, compared to their WT counterparts (Fig. 3a,b and Supplementary Fig. 3 ). Microscopic examination of thick liver sections from WT and Ifnar1 −/− mice 48 h after infection revealed that in the absence of type I IFN-dependent signaling, the number of liver-stage parasites was substantially increased (Fig. 3c,d) . When we initiated infections even with low numbers (500) of P. berghei sporozoites, we detected parasites in the blood 1 d earlier in Ifnar1 −/− mice than in WT mice, which is reflected in significant differences in blood-stage parasitemia (Fig. 3e) . Furthermore, mice lacking Ifnar in hepatocytes only (Alb-Cre-Ifnar1 flox/flox ) had a significant increase Table 2 . Data are expressed as means ± s.e.m. *P < 0.05; **P < 0.01; ***P < 0.001. npg in both parasite liver load and blood-stage parasitemia as compared to their WT counterparts (Fig. 3f,g ), demonstrating that the differences in blood-stage parasitemia are mainly due to hepatocyte-mediated type I IFN signaling. This highlights the impact of liver-specific type I IFN on total parasite biomass during initiation of blood-stage infection, which influences malaria severity 29 .
We next sought to determine whether a functional antiplasmodial type I IFN response could be triggered by other hepatotropic pathogens, such as hepatitis C virus (HCV), which is highly prevalent in malaria-endemic areas 30 . Hydrodynamic tail vein injection of HCV RNA before P. berghei sporozoite infection led to a significant reduction in parasite liver load at 48 h after infection in an Ifnar1-dependent manner (Fig. 3h) . Overall, we demonstrate that an innate immune antiparasitic response contributes to host resistance during Plasmodium liver-stage infection and raise the possibility of a role for type I IFN signaling in the interplay between hepatotropic infections in humans.
Liver leukocytes are critical in parasite elimination Finally, we sought to gain insight into the effector mechanisms by which the type I IFN response increases host resistance to liver-stage Plasmodium parasites. During viral infections, ISGs can act as effectors directly mediating the type I IFN antiviral defense, with different viruses being targeted by unique sets of ISGs 11 . Exogenous induction of a type I IFN response by 5,6-dimethylxanthenone-4-acetic acid (DMXAA, a drug that activates Irf3 (refs. 31,32)) led to a significant Ifnar1-dependent reduction in liver-stage infection in vivo, but not in mouse primary hepatocytes ex vivo (Fig. 4a,b and Supplementary  Fig. 4 ). This result suggests that the hepatocyte-mediated response is not able to eliminate the parasite and indicates that although hepatocytes are essential for the propagation of the type I IFN response, other cells may be required as effectors in parasite elimination.
The type I IFN response is known to activate and recruit immune cells to the site of bacterial infection 33 , and inflammatory cells have been noted to infiltrate the livers of Plasmodium-infected mice 6, 7, 9 . Thus, we next tested whether the presence of these inflammatory cells in the liver during Plasmodium infection could depend on the type I IFN response. We observed that the number of infected hepatocytes surrounded by infiltrates increases with time after the peak of type I IFN response in an Ifnar-dependent manner (Fig. 4c,d ), consistent with a role for the type I IFN response in establishing these infiltrates around infected cells. We would therefore expect these infiltrating leukocytes to show a characteristic IFN response, and indeed, leukocytes purified from infected livers (including both infiltrating and resident cells) showed significant ISG induction at 48 h, whereas the purified hepatocyte populations showed a peak at 42 h (Fig. 4e) . Moreover, the number of infected hepatocytes surrounded by immune cells was significantly reduced in P. berghei-infected mice lacking Ifnar1 specifically on myeloid cells (LysM-Cre-Ifnar1 flox/flox ), including macrophages and neutrophils (Fig. 4f) . Thus, our data indicate that leukocytes capable of responding to type I IFN are mobilized to the vicinity of infected hepatocytes by hepatocyte-propagated type I IFN signaling. LysM-Cre-Ifnar1 flox/flox mice also had a significantly higher parasite liver load compared to WT mice at 48 h, i.e., when leukocytes themselves were responding to type I IFN; consistent with our previous results, this effect on parasite load was not present at 42 h, when infiltrates were not yet numerous and leukocytes lacked significant ISG induction (Fig. 4d-g ). Overall, these data suggest that the ISG response induced in hepatocytes by Plasmodium liver infection is not able to eliminate Plasmodium parasites directly and that hepatocyte-driven propagation of the type I IFN signaling after the initial sensing events is critical for a later recruitment and induction of a type I IFN response in leukocytes, which probably act as effectors, playing a key role in parasite elimination (Fig. 5) . (Fig. 5) . Additionally, RNA may not be the only Plasmodium PAMP detected in the liver; non-nucleic acids may also contribute, as recently suggested for HIV-1 infection 35 . Our results suggest a model in which the activation of the cytosolic signaling pathways leads to the release of type I IFNs into the extracellular environment where it binds to Ifnar on the surface of hepatocytes, propagating the response in an autocrine and paracrine manner via the production of ISGs. We hypothesize that chemoattractant molecules released from type I IFN-producing hepatocytes activate and recruit leukocytes to the liver, where they would be further targeted specifically to infected hepatocytes (see Fig. 5 ). Future studies should decipher the exact mechanisms at work in this recruitment and the chemoattractant molecules involved. Our work reveals that the host does not remain passive during the liver stage of infection. On the contrary, the host innate immune system has developed ways to recognize and control parasite load during the first obligatory step of Plasmodium infection in the mammalian host, as well as to reduce the number of parasites able to emerge from the liver and initiate the blood stage of infection. Although this innate immune response does not eliminate every parasite, which implies that the parasite has probably devised strategies to counteract it 5, 6 , the observed reduction in surviving exoerythrocytic forms may be physiologically important on a population level, by decreasing parasite genetic diversity in the resulting blood-stage population. This is highly relevant knowledge for new drug and vaccine strategies, as the type I IFN response might reduce the likelihood of transmission of drug-resistant parasites or the escape of attenuated parasites used in vaccination. Further, using adjuvants (for liver-stagetargeted vaccines) or prophylactics that enhance the potency of the host's natural type I IFN response could lead to a better control of liver-stage parasites. Notably, our data demonstrate that preactivation of a type I IFN response impairs the establishment of Plasmodium infection. This observation is clinically relevant for most populations exposed to malaria, as they not only face multiple re-infections with Plasmodium 10 but also are commonly infected with hepatotropic pathogens such as HCV 36, 37 , increasing the likelihood of interference between various pathogens and the immune response within a single host. These results highlight the fact that host-pathogen interactions can no longer be perceived as a dialog between a host and a single pathogen of interest, but rather as nodes of complex interactions modulated by the host's entire network of symbionts and pathogens. Undeniably, further investigation of both host recognition mechanisms and subversion strategies that the parasite has most certainly developed over million years of coevolution will be useful not only for malaria vaccine development but also for the sustained success of both malaria-control and Plasmodium-elimination agendas.
METHODS
Methods and any associated references are available in the online version of the paper. Figure 5 Schematic representation of the proposed sequence of events occurring in the liver after Plasmodium infection. Infection of hepatocytes by Plasmodium parasites induces a type I IFN response, which is triggered in liver-resident cells by Plasmodium RNA via the cytoplasmic RNA sensor Mda5 and other unknown receptors, Mavs and the transcription factors Irf3 and Irf7 (1). Type I IFNs are then released in the extracellular environment (2) . It binds to Ifnar on the surface of hepatocytes, propagating the response in an autocrine and paracrine manner (3). In turn, Ifnar activation leads to the upregulation of ISG transcription (including chemokines) and propagation of the response throughout the entire liver (4). IFN and the chemokines released from hepatocytes activate (5) and direct (6) innate immune cells to the infected hepatocytes, which have a key role in parasite elimination (7) . 
